SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-10-004763
Filing Date
2010-05-04
Accepted
2010-05-04 16:36:50
Documents
5
Period of Report
2010-06-07
Effectiveness Date
2010-05-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2198447zdef14a.htm DEF 14A 638049
2 G732404.JPG g732404.jpg GRAPHIC 9536
3 G51755.JPG g51755.jpg GRAPHIC 47496
4 G364352BCI001.GIF g364352bci001.gif GRAPHIC 79314
5 G364352BCI002.GIF g364352bci002.gif GRAPHIC 93275
  Complete submission text file 0001047469-10-004763.txt   956569
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 10797700
SIC: 2834 Pharmaceutical Preparations